🇺🇸 FDA
Patent

US 11465976

1,2,4-oxadiazole and thiadiazole compounds as immunomodulators

granted A61KA61K31/4245A61K38/05

Quick answer

US patent 11465976 (1,2,4-oxadiazole and thiadiazole compounds as immunomodulators) held by Aurigene Discovery Technologies Limited expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aurigene Discovery Technologies Limited
Grant date
Tue Oct 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/4245, A61K38/05, A61K45/06, A61P